Literature DB >> 10488815

The influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease.

R S Doody1, J L Vacca, P J Massman, T Y Liao.   

Abstract

BACKGROUND: Research on the influence of handedness on the clinical presentation and neuropsychology of Alzheimer disease (AD) is scarce.
OBJECTIVE: To compare clinical presentation and neuropsychological test performance of right- and left-handed patients with AD.
DESIGN: We hypothesized that left-handedness would be associated with younger onset, more rapid progression, and possibly cognitive hemispheric asymmetry. After determining handedness with the Edinburgh Inventory for Handedness for 922 patients with AD, 18 left-handed patients were compared with 18 right-handed patients matched individually on Mini-Mental State Examination scores, education, and age. We compared clinical characteristics (eg, age of onset), estimated rate of initial cognitive decline, language and visuospatial test performances, and patterns of cognitive and motor asymmetries for the 2 groups.
SETTING: Alzheimer's Disease Research Center at Baylor College of Medicine, Houston, Tex. MAIN OUTCOME MEASURES: Results of the Wechsler Adult Intelligence Scale-Revised verbal and performance IQ tests, the Western Aphasia Battery sequential commands subtest, the Boston Naming Test, the Halstead-Reitan Finger-Tapping Test, and the calculated Rate of Initial Progression.
RESULTS: We found that left-handed patients had younger ages of onset but unexpectedly lower estimated rates of initial cognitive decline, and their results on language tests did not differ from those of right-handed patients. Regarding asymmetry, left-handed patients were more likely than right-handers to obtain lower verbal IQ than performance IQ scores and to exhibit faster finger-tapping speeds with their nondominant hand, but group differences did not attain statistical significance. There were disproportionately few left-handed patients with AD compared with population norms.
CONCLUSIONS: Left-handed patients with AD do not differ from right-handed patients in the severity or pattern of neuropsychological deficits. Left-handedness or some factor associated with it may contribute to the early appearance of cognitive deficits during the development of Alzheimer disease, but may temper the subsequent rate of progression of deficits.

Entities:  

Mesh:

Year:  1999        PMID: 10488815     DOI: 10.1001/archneur.56.9.1133

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

Review 1.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

2.  Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Authors:  Cheryl L P Vigen; Wendy J Mack; Richard S E Keefe; Mary Sano; David L Sultzer; T Scott Stroup; Karen S Dagerman; John K Hsiao; Barry D Lebowitz; Constantine G Lyketsos; Pierre N Tariot; Ling Zheng; Lon S Schneider
Journal:  Am J Psychiatry       Date:  2011-05-15       Impact factor: 18.112

3.  Handedness and cognitive function in older men and women: a comparison of methods.

Authors:  B Siengthai; D Kritz-Silverstein; E Barrett-Connor
Journal:  J Nutr Health Aging       Date:  2008-11       Impact factor: 4.075

4.  APOE genotype is associated with left-handedness and visuospatial skills in children.

Authors:  Cinnamon S Bloss; Dean C Delis; David P Salmon; Mark W Bondi
Journal:  Neurobiol Aging       Date:  2008-07-07       Impact factor: 4.673

5.  Mixed handedness is associated with greater age-related decline in volumes of the hippocampus and amygdala: the PATH through life study.

Authors:  Nicolas Cherbuin; Perminder S Sachdev; Kaarin J Anstey
Journal:  Brain Behav       Date:  2011-11       Impact factor: 2.708

Review 6.  Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.

Authors:  Valory N Pavlik; Samantha C Burnham; Joseph S Kass; Catherine Helmer; Sebastian Palmqvist; Maria Vassilaki; Jean-François Dartigues; Oskar Hansson; Colin L Masters; Karine Pérès; Ronald C Petersen; Erik Stomrud; Lesley Butler; Preciosa M Coloma; Xavier M Teitsma; Rachelle Doody; Mary Sano
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.